Pablo Martinez - Publications

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).

Journal: PloS one

Published: October 17, 2014

Ganitumab for the treatment of small-cell lung cancer.

Journal: Expert opinion on investigational drugs

Published: September 06, 2014

Molecular targeted therapy for early-stage non-small-cell lung cancer: will it increase the cure rate?

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 06, 2014

Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 13, 2013

Adjuvant treatment of resected nonsmall cell lung cancer: state of the art and new potential developments.

Journal: Current opinion in oncology

Published: December 25, 2012

Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patients.

Journal: PloS one

Published: June 25, 2012

Bone metastases with nerve root compression as a late complication in patient with epithelial pleural mesothelioma.

Journal: Journal of thoracic disease

Published: May 11, 2012

A phase Ib, dose-finding study of erlotinib in combination with a fixed dose of pertuzumab in patients with advanced non-small-cell lung cancer.

Journal: Clinical lung cancer

Published: December 16, 2011

Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 22, 2011